Դանիա -
դանիերեն -
Lægemiddelstyrelsen (Danish Medicines Agency)
klacid sr 500 mg depottabletter
paranova danmark a/s - clarithromycin - depottabletter - 500 mg
Դանիա -
դանիերեն -
Lægemiddelstyrelsen (Danish Medicines Agency)
cyclophosphamid "2care4" 50 mg overtrukne tabletter
2care4 aps - cyclophosphamid, vandfrit - overtrukne tabletter - 50 mg
Դանիա -
դանիերեն -
Lægemiddelstyrelsen (Danish Medicines Agency)
cyclophosphamid "2care4" 1 g pulver til injektionsvæske, opløsning
2care4 aps - cyclophosphamid, vandfrit - pulver til injektionsvæske, opløsning - 1 g
Դանիա -
դանիերեն -
Lægemiddelstyrelsen (Danish Medicines Agency)
ozalin 2 mg/ml oral opløsning, enkeltdosisbeholder
primex pharmaceuticals oy - midazolam - oral opløsning, enkeltdosisbeholder - 2 mg/ml
Դանիա -
դանիերեն -
Lægemiddelstyrelsen (Danish Medicines Agency)
timonil retard 300 mg depottabletter
2care4 aps - carbamazepin - depottabletter - 300 mg
Դանիա -
դանիերեն -
Lægemiddelstyrelsen (Danish Medicines Agency)
warfarinnatrium "2care4" 2,5 mg tabletter
2care4 aps - warfarinnatrium - tabletter - 2,5 mg
Դանիա -
դանիերեն -
Lægemiddelstyrelsen (Danish Medicines Agency)
zoloft 25 mg filmovertrukne tabletter
2care4 aps - sertralinhydrochlorid - filmovertrukne tabletter - 25 mg
Եվրոպական Միություն -
դանիերեն -
EMA (European Medicines Agency)
copiktra
secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastiske midler - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies. follicular lymphoma (fl) that is refractory to at least two prior systemic therapies.
Դանիա -
դանիերեն -
Lægemiddelstyrelsen (Danish Medicines Agency)
sertralin "zentiva" 25 mg filmovertrukne tabletter
zentiva k.s. - sertralinhydrochlorid - filmovertrukne tabletter - 25 mg
Եվրոպական Միություն -
դանիերեն -
EMA (European Medicines Agency)
brukinsa
beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastiske midler - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).